Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?
2014 Value in health
Millier, A. | Briquet, B. | Aballea, S. | Toumi, M. |
Cost-effectiveness analyses (CEA) are used to support funding decisions for new drugs by estimating their clinical and economic value. While prices of drugs may fall over time due to market competition, entrance of generic drugs, or negotiated price cuts, this is rarely accounted for in CEA. The objective is to review pharmacoeconomic guidelines and current practice around drug price evaluation in CEA.